Cargando…

Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014

BACKGROUND: The Value-Based Health Care concept defines patient value as patient-relevant outcomes divided by costs. The aim of the present study was to assess the development of systemic treatment costs over the years compared with changes in overall survival (OS) at the level of a diagnosis of sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cramer-van der Welle, Christine M., Peters, Bas J. M., Deenen, Maarten J., Schramel, Franz M. N. H., van de Garde, Ewoudt M. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895888/ https://www.ncbi.nlm.nih.gov/pubmed/32533521 http://dx.doi.org/10.1007/s41669-020-00220-z

Ejemplares similares

Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2018)

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2021)

Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands
por: Mfumbilwa, Zakile A., et al.
Publicado: (2023)

Real‐world treatment patterns and outcomes of patients with extensive disease small cell lung cancer
por: Cramer‐van der Welle, Christine M., et al.
Publicado: (2020)

Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands
por: Reesink, Daan J., et al.
Publicado: (2020)

Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups
por: Al Khayat, Mohamed N. M. T., et al.
Publicado: (2022)

The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC
por: Verschueren, M. V., et al.
Publicado: (2021)

The dynamics in applied COVID-19 pharmacotherapy and the influence of national guidance in The Netherlands: a quantitative and qualitative study
por: Uitvlugt, Elien B, et al.
Publicado: (2022)

‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer
por: Cramer-van der Welle, Christine M, et al.
Publicado: (2021)

Measles Outbreak, the Netherlands, 2008
por: Hahné, Susan, et al.
Publicado: (2010)

Pharmacotherapy within a learning healthcare system: rationale for the Dutch Santeon Farmadatabase
por: van de Garde, Ewoudt M W, et al.
Publicado: (2019)

Consecutive antibiotic use in the outpatient setting: an extensive, longitudinal descriptive analysis of antibiotic dispensing data in the Netherlands
por: de Jong, Loek A. W., et al.
Publicado: (2019)

Human Leptospirosis Trends, the Netherlands, 1925–2008
por: Goris, Marga G.A., et al.
Publicado: (2013)

Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008
por: Kuiper, Edith MM, et al.
Publicado: (2010)

Trends in Individualized Affordability of Factory-Made Cigarettes: Findings of the 2008–2020 International Tobacco Control Netherlands Surveys
por: Geboers, Cloé, et al.
Publicado: (2022)

Dementia incidence trend over 1992-2014 in the Netherlands: Analysis of primary care data
por: van Bussel, Emma F., et al.
Publicado: (2017)

Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy
por: Bui, Tam Binh V, et al.
Publicado: (2019)

Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC
por: Ismail, R. K., et al.
Publicado: (2023)

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC
por: Ismail, R. K., et al.
Publicado: (2023)

Underdiagnosis of Foodborne Hepatitis A, the Netherlands, 2008–2010
por: Petrignani, Mariska, et al.
Publicado: (2014)

Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer
por: Révész, Dóra, et al.
Publicado: (2019)

Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992–2008
por: Lemmens, V. E. P. P., et al.
Publicado: (2011)

Trends in incidence and costs of injuries to the shoulder, arm and wrist in The Netherlands between 1986 and 2008
por: Polinder, Suzanne, et al.
Publicado: (2013)

Trends in overall survival and costs of multiple myeloma, 2000–2014
por: Fonseca, R, et al.
Publicado: (2017)

GMP-compliant (68)Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use
por: Vis, Roeland, et al.
Publicado: (2015)

Iodized Salt in Cambodia: Trends from 2008 to 2014
por: Laillou, Arnaud, et al.
Publicado: (2015)

Causes of perioperative hypersensitivity reactions in the Netherlands from 2002 to 2014
por: van de Ven, Annick A. J. M., et al.
Publicado: (2021)

Think regionally, act locally: metals in honeybee workers in the Netherlands (surveillance study 2008)
por: van der Steen, J. J. M., et al.
Publicado: (2016)

Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008
por: Wieberdink, Renske G., et al.
Publicado: (2012)

Antibiotic prescribing on admission to patients with pneumonia and prior outpatient antibiotic treatment: a cohort study on clinical outcome
por: van de Garde, Ewoudt M W, et al.
Publicado: (2015)

Antidepressants and lethal violence in the Netherlands 1994–2008
por: Bouvy, Paul F., et al.
Publicado: (2012)

Trends in the Prevalences of Selected Birth Defects in Korea (2008–2014)
por: Ko, Jung-Keun, et al.
Publicado: (2018)

Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative
por: Reesink, Daan J., et al.
Publicado: (2021)

Human polyomavirus KI and WU in adults with community acquired pneumonia in The Netherlands, 2008–2009
por: Huijskens, Elisabeth G.W., et al.
Publicado: (2010)

Listeria monocytogenes meningitis in the Netherlands, 1985–2014: A nationwide surveillance study
por: Koopmans, Merel M., et al.
Publicado: (2017)

Molecular characterization of MRSA collected during national surveillance between 2008 and 2019 in the Netherlands
por: Schouls, Leo M., et al.
Publicado: (2023)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Economic Costs of Measles Outbreak in the Netherlands, 2013–2014
por: Suijkerbuijk, Anita W.M., et al.
Publicado: (2015)

Hepatitis B virus infected health care workers in the Netherlands, 2000-2008
por: Daha, T. J., et al.
Publicado: (2009)

Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology
por: Woudenberg, Tom, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i6j75c2o16m6fgs74uiknflshr